Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
2020 · Cell Research · 877 citations
https://doi.org/10.1038/s41422-020-0356-z
Y
Yanmei Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
5.3K
Citations
34
h-index
70
i10-index
Yanmei Hu is an academic researcher from Rutgers, The State University of New Jersey. The author has contributed to research in topics: RNA and protein synthesis mechanisms & SARS-CoV-2 and COVID-19 Research & Computational Drug Discovery Methods. The author has an h-index of 34, co-authored 97 publications.
ORCID: 0000-0003-0525-7342Papers by this author
worksAI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 114 citations
https://doi.org/10.1038/s41598-024-54655-z
Enterovirus A71 antivirals: Past, present, and future
2021 · Acta Pharmaceutica Sinica B · 92 citations
https://doi.org/10.1016/j.apsb.2021.08.017
Bright, efficient, and stable pure-green hyperfluorescent organic light-emitting diodes by judicious molecular design
2024 · Nature Communications · 71 citations
https://doi.org/10.1038/s41467-024-47482-3
Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses
2018 · Journal of Medicinal Chemistry · 34 citations
https://doi.org/10.1021/acs.jmedchem.8b00042
FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 Mpro and PLpro
2023 · STAR Protocols · 10 citations
https://doi.org/10.1016/j.xpro.2023.102323
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat